Return to content in this issue


Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study

Caruso C1, Borgonovo L2, Bramé B3, Cocconcelli A4, Colantuono S5, Piantanida M6, Scarpa S7, Zisa G8, Romano A1

1Allergy Unit – Fondazione Policlinico Gemelli –Presidio Columbus, Rome, Italy
2Allergy and Clinical Immunology Department, ASST Fatebenefratelli Sacco, Milan, Italy
3Clinical Allergy and Immunology Unit, Legnano Hospital, Legnano, Italy
4Allergy Outpatient Clinic, AUSL Reggio Emilia, Reggio Emilia, Italy
5Clinical Medicine Department and Molecular Medicine Department, Sapienza University, Rome, Italy
6Clinical Allergy and Immunology Unit, Foundation IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy
7Clinical Allergy and Immunology Unit, AUSL Parma, Parma, Italy
8Allergology and Immunology Unit, Novara Hospital, Novara, Italy

J Investig Allergol Clin Immunol 2018; Vol 28(4) : 283-284
doi: 10.18176/jiaci.0269

Key words: Accelerated dose escalation, Allergoid, Safety, Subcutaneous immunotherapy, Tolerability